Abstract

In recent years, the rapid development and employment of autonomous technology have been observed in many areas of human activity. Autonomous technology can readily adjust its function to environmental conditions and enable an efficient operation without human control. While applying the same concept to designing advanced biomolecular therapies would revolutionize nanomedicine, the design approaches to engineering biological nanocomputing agents for predefined operations within living cells remain a challenge. Autonomous nanocomputing agents made of nucleic acids and proteins are an appealing idea, and two decades of research has shown that the engineered agents act under real physical and biochemical constraints in a logical manner. Throughout all domains of life, nucleic acids and proteins perform a variety of vital functions, where the sequence-defined structures of these biopolymers either operate on their own or efficiently function together. This programmability and synergy inspire massive research efforts that utilize the versatility of nucleic and amino acids to encode functions and properties that otherwise do not exist in nature. This Perspective covers the key concepts used in the design and application of nanocomputing agents and discusses potential limitations and paths forward.

MeSH

Cells, Nucleic Acids, Research, Nanotechnology

Cited by

• Optogenetic enzymes: A deep dive into design and impact. Curr Opin Struct Biol, 2025
• Leveraging Immunological Properties of Nucleic Acid Nanoparticles to Improve Cancer Therapy. RNA Nanomed, 2025
• The Evolving Landscape of Protein Allostery: From Computational and Experimental Perspectives. J Mol Biol, 2025
• Nucleic acid nanobiosystems for cancer theranostics: an overview of emerging trends and challenges. Nanomedicine (Lond), 2025